Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.